The plant in the Santiago region will be able to fill and finish some 50 million doses annually, and should be ready before 2023 Chinese pharmaceutical Sinovac Biotech Ltd which makes one of the ...
Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal ...
BEIJING — Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company“), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback